Obesity: effects on cardiovascular disease and its diagnosis

Boban Mathew1, Lisa Francis, Attila Kayalar

  • 1Department of Cardiology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA. bmathew6@yahoo.com

Insights

Obesity increases cardiovascular disease risk, both indirectly through factors like hypertension and directly via its effects on the heart. This study explores these direct impacts and challenges in cardiac investigations.

Area of Science:

  • Cardiology
  • Obesity Medicine
  • Public Health

Background:

  • Obesity is a major global health concern linked to increased cardiovascular disease (CVD) prevalence.
  • CVD risk in obese individuals is often attributed to associated metabolic risk factors such as hypertension, diabetes, and dyslipidemia.
  • The metabolic syndrome, a cluster of these conditions, further exacerbates CVD risk.

Purpose of the Study:

  • To elucidate the direct mechanisms by which obesity impacts the cardiovascular system.
  • To detail the challenges encountered in performing and interpreting cardiac investigations in obese patients.
  • To propose solutions for overcoming these diagnostic challenges.

Main Methods:

  • Review of existing literature on obesity and cardiovascular physiology.
  • Analysis of studies investigating the direct effects of adipose tissue on cardiac function.
  • Examination of case studies and research on imaging and electrophysiological testing in obesity.

Main Results:

  • Obesity directly alters cardiac structure and function, including left ventricular hypertrophy and diastolic dysfunction.
  • Increased frequency of hypertension, diabetes, and dyslipidemia are significant indirect mediators of CVD in obesity.
  • Challenges in cardiac investigations include reduced image quality, altered signal detection, and difficulties in patient positioning.

Conclusions:

  • Obesity has multifaceted detrimental effects on the cardiovascular system, acting both directly and indirectly.
  • Addressing obesity is crucial for CVD prevention and management.
  • Strategies are needed to optimize cardiac investigations for accurate diagnosis and effective management in obese populations.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...